IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SINAGRA, Gianfranco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.676
AS - Asia 1.898
EU - Europa 993
SA - Sud America 393
Continente sconosciuto - Info sul continente non disponibili 70
AF - Africa 48
OC - Oceania 4
Totale 6.082
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.573
SG - Singapore 672
CN - Cina 483
BR - Brasile 336
HK - Hong Kong 261
IT - Italia 253
DE - Germania 162
VN - Vietnam 135
BD - Bangladesh 123
FI - Finlandia 108
FR - Francia 85
GB - Regno Unito 77
RU - Federazione Russa 76
UA - Ucraina 76
CA - Canada 63
TR - Turchia 63
IN - India 56
IE - Irlanda 36
JP - Giappone 24
MX - Messico 23
PL - Polonia 21
ZA - Sudafrica 17
IQ - Iraq 16
AR - Argentina 15
SE - Svezia 15
ES - Italia 14
NL - Olanda 14
AT - Austria 13
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
MA - Marocco 10
EC - Ecuador 8
LT - Lituania 8
KE - Kenya 7
PK - Pakistan 7
CL - Cile 6
CO - Colombia 6
PY - Paraguay 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
AZ - Azerbaigian 4
BE - Belgio 4
BG - Bulgaria 4
BO - Bolivia 4
CH - Svizzera 4
PH - Filippine 4
CR - Costa Rica 3
EG - Egitto 3
ID - Indonesia 3
JM - Giamaica 3
LK - Sri Lanka 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
SC - Seychelles 3
TN - Tunisia 3
AM - Armenia 2
GR - Grecia 2
IL - Israele 2
NP - Nepal 2
PS - Palestinian Territory 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
Totale 6.015
Salva come PNG Salva come JPEG
Città #
Ashburn 356
Singapore 332
Hong Kong 260
San Jose 235
Beijing 150
The Dalles 116
New York 113
Fairfield 111
Los Angeles 93
Helsinki 78
Dallas 77
Woodbridge 66
Seattle 58
Chandler 57
Jacksonville 56
Lauterbourg 56
Munich 55
Istanbul 54
Columbus 52
Ho Chi Minh City 52
Wilmington 44
Council Bluffs 42
Houston 42
Princeton 40
São Paulo 39
Cambridge 37
Dublin 36
Buffalo 34
Milan 34
Orem 33
Hanoi 31
Romola 27
Redondo Beach 26
Santa Clara 26
Ann Arbor 25
Montreal 25
San Francisco 25
Shanghai 25
Moscow 23
Chennai 21
Chicago 20
Tokyo 20
Brescia 19
Washington 19
Turku 18
Warsaw 18
Frankfurt am Main 17
Rome 17
Brooklyn 16
Nanjing 16
London 15
Atlanta 14
Boston 14
Guangzhou 14
Nuremberg 14
Toronto 14
Poplar 12
Denver 11
Des Moines 11
Dearborn 10
Hangzhou 10
Johannesburg 10
Lappeenranta 10
Stockholm 10
Belo Horizonte 9
Brno 9
City of London 9
Phoenix 9
Brasília 8
Dhaka 8
Haiphong 8
Hebei 8
Rio de Janeiro 8
San Diego 8
Vienna 8
Amsterdam 7
Boydton 7
Düsseldorf 7
Naples 7
Salvador 7
Ankara 6
Curitiba 6
Da Nang 6
Mumbai 6
Novara 6
Paris 6
Querétaro 6
Baghdad 5
Charlotte 5
Hải Dương 5
Jinan 5
Lahore 5
Manchester 5
Mexico City 5
Miami 5
Nairobi 5
Newark 5
Pune 5
Salt Lake City 5
Sete Lagoas 5
Totale 3.645
Salva come PNG Salva come JPEG
Nome #
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 162
Heart failure and anemia: Effects on prognostic variables 151
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 147
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 145
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 145
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 135
[Italian Society of Cardiology (SIC) Position paper: Technical, instrumental and standards of interpretation for electrocardiography, ambulatory electrocardiographic and blood pressure monitoring in telemedicine] 131
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 130
The chronic heart failure evolutions: Different fates and routes 125
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 121
ANMCO / FADOI / SIAARTI / SIC / SIMG / SIMI / SIMEU Consensus Document: The clinical-diagnostic and therapeutic pathway of the patient with acute heart failure from home to discharge from the Emergency Room / Emergency Department-Acceptance 121
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 117
The prognostic value of serial troponin measurements in patients admitted for COVID-19 117
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 109
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials] 109
[2022 Update on myocarditis and pericarditis following COVID-19 vaccination. Expert Opinion of the Italian Society of Cardiology] 108
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 108
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 107
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome] 104
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 103
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 101
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 99
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice] 98
[Palliative inotrope therapy in advanced heart failure: organization and management] 98
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 97
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 95
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 94
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 93
[Transcatheter devices for chronic heart failure: state of the art] 90
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 88
Impact of malnutrition in patients with severe heart failure 88
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 87
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 87
[Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology] 86
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry 86
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 86
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 85
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 84
Atrial signal amplitude predicts atrial high-rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring trasmissions 83
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 83
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 80
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 78
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 77
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 76
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 75
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 74
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 73
[Italian Society of Cardiology (SIC) Expert consensus document: Post-acute cardiovascular sequelae of SARS-CoV-2 infection] 70
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration 69
Palliative care in the cardiac setting: A consensus document of the Italian Society of Cardiology (SIC) and Italian Society of Palliative Care (SICP) Joint Working Group 67
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 65
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry 65
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 64
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 64
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 63
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 62
Effects of the COVID-19 pandemic on the formation of fellows in training in cardiology 62
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 62
Management of hypertrophic cardiomyopathy 62
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 60
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries 59
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 57
Correction to: SARS‑CoV‑2, myocardial injury and inflammation: insights from a large clinical and autopsy study 53
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 50
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 50
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination 49
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology 47
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study 46
Totale 6.082
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.293
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022117 0 5 5 9 1 5 1 9 7 16 19 40
2022/2023238 37 23 4 4 11 52 2 23 51 3 14 14
2023/2024637 35 13 68 60 43 111 39 23 111 25 26 83
2024/20251.317 15 12 43 144 97 100 173 69 120 91 248 205
2025/20262.919 270 387 205 390 341 213 337 127 195 195 182 77
2026/2027232 158 74 0 0 0 0 0 0 0 0 0 0
Totale 6.082